This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, M

 Previous Article  |  Next Article 

Infect Immun. 1991 May; 59(5): 1857-1859

Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

M Denis

Unité de Recherche, Hôpital Laval, Chemin Sainte-Foy, Québec, Canada.

ABSTRACT

Susceptible BALB/c mice were infected with Mycobacterium avium TMC 702. Groups of mice were then infused with 10(4) U (approximately 400 U/h) of murine beta interferon (IFN-beta) via a minipump system, and the progression of the infection was assessed. Mice infused with IFN-beta showed superior resistance to infection, as determined by reduced bacterial growth in the livers and spleens of infected animals, (1-log reduction in bacterial CFU at 2 months postinfection; P less than 0.001). This was corroborated by the fact that resident peritoneal macrophages treated with IFN-beta in vitro (10(2) U/ml) were more bacteriostatic for M. avium TMC 702 than their untreated counterparts. Overall, these findings suggest an important role for IFN-beta in mycobacterial infections.

Infect Immun. 1991 May; 59(5): 1857-1859




This article has been cited by other articles:

  • Rothfuchs, A. G., Trumstedt, C., Mattei, F., Schiavoni, G., Hidmark, A., Wigzell, H., Rottenberg, M. E. (2006). STAT1 Regulates IFN-{alpha}beta- and IFN-{gamma}-Dependent Control of Infection with Chlamydia pneumoniae by Nonhemopoietic Cells.. J. Immunol. 176: 6982-6990 [Abstract] [Full Text]  
  • Schiavoni, G., Mauri, C., Carlei, D., Belardelli, F., Castellani Pastoris, M., Proietti, E. (2004). Type I IFN Protects Permissive Macrophages from Legionella pneumophila Infection through an IFN-{gamma}-Independent Pathway. J. Immunol. 173: 1266-1275 [Abstract] [Full Text]  
  • Mattner, J., Wandersee-Steinhauser, A., Pahl, A., Rollinghoff, M., Majeau, G. R., Hochman, P. S., Bogdan, C. (2004). Protection against Progressive Leishmaniasis by IFN-{beta}. J. Immunol. 172: 7574-7582 [Abstract] [Full Text]  
  • Utaisincharoen, P., Anuntagool, N., Limposuwan, K., Chaisuriya, P., Sirisinha, S. (2003). Involvement of Beta Interferon in Enhancing Inducible Nitric Oxide Synthase Production and Antimicrobial Activity of Burkholderiapseudomallei-Infected Macrophages. Infect. Immun. 71: 3053-3057 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»